Cormedix Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the results of the Annual Meeting of Stockholders held by Cormedix Inc. on December 9, 2021. The filing covers the voting outcomes for four specific proposals submitted to holders of common stock, Series E Preferred Stock, and Series G Preferred Stock.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and voting results rather than financial performance.
Material Changes and Voting Results
Four proposals were voted upon at the Annual Meeting:
- Proposal 1 (Election of Directors): All six nominees were elected to the Board of Directors. Significant broker non-votes (13,796,257) were recorded for each nominee. Myron Kaplan received the highest number of withheld votes (2,294,718) compared to other nominees.
- Proposal 2 (Say-on-Pay): The advisory vote on executive compensation was approved with 12,021,602 votes FOR and 1,383,432 votes AGAINST.
- Proposal 3 (Frequency of Say-on-Pay): Stockholders approved an annual frequency for future advisory votes on executive compensation. The "Every Year" option received 11,358,401 votes, while "Three Years" received 1,856,010 votes.
- Proposal 4 (Ratification of Auditors): The appointment of Friedman LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021, was ratified with 26,038,231 votes FOR.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management commentary on outlook, specific risks, contingencies, or unusual items. The document is limited to the disclosure of voting results.
Key Facts for Investor Verification
- Verify the total number of shares outstanding and the proportion of broker non-votes relative to total shares to understand the effective voting power.
- Confirm the specific terms of the Series E and Series G Preferred Stock regarding their voting rights and conversion features.
- Review the full Proxy Statement for detailed information on the executive compensation package approved in Proposal 2.
- Check subsequent filings for the company's financial status, as this 8-K contains no financial data.